Safety and efficacy of perampanel as adjunctive therapy in refractory partial seizures

Description:
Seizures are abnormal electrical impulses in the brain. The signs and symptoms of seizures vary depending on the type of seizure a patient has. This study is looking at the use of perampanel in patients that have partial-onset seizures that are not currently controlled

Medication Under Study:
Perampanel (E2007)

Full study title:
An Open-Label Extension Phase of the Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Studies to Evaluate the Efficacy and Safety of E2007 (perampanel) Given as Adjunctive Therapy in Subjects with Refractory Partial Seizures

IRB Study ID:
080705


Who may qualify:

Patients who have participated in other studies involving perampanel for their partial onset seizures

Who does not qualify:

Patients who did not previously complete or participate in earlier studies of perampanel

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-5012

For urgent patient care matters involving a current study patient, please call: 330-920-5774


Lead Principal Investigator:

Photo
Thomas Enlow, MD
Pediatric Neurologist


Bookmark and Share

iGrow iGrow
Sign up for our parent enewsletter
    Contact Us

    330-543-5012

    E-mail

    find a location
    Find a location Type the first 3-5 letters of a specialty, service or location:
    Or, view: a map, a list of all locations, locations by city or locations near me.
    find a doctor
    Find a doctor Type the first 3-5 letters of the name, location or specialty:
    Or, view a list of all doctors by name, location and specialty.